Latest News about MGNX
Recent news which mentions MGNX
Demystifying Macrogenics: Insights From 5 Analyst Reviews
January 24, 2024
Tickers
MGNX
From Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
January 19, 2024
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in January
January 15, 2024
From InvestorPlace
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 20, 2023
From Benzinga
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
December 20, 2023
From Benzinga
Top 4 Health Care Stocks That May Crash This Month
December 20, 2023
From Benzinga
From Benzinga
Forecasting The Future: 4 Analyst Projections For Macrogenics
December 20, 2023
Tickers
MGNX
From Benzinga
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
From InvestorPlace
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 07, 2023
From Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
From Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
From Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
August 19, 2023
From Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
August 10, 2023
From Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 10, 2023
From Benzinga
Why Shares of MacroGenics Are Jumping Thursday
August 10, 2023
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 03, 2023
From Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.